What is considered Biohazardous waste?

10/24/2018 (Permalink)

Biohazardous waste includes the following materials:

1. Human blood and blood products: All human blood, blood products (such as serum, plasma, and other blood components) in liquid or semi-liquid form. Items contaminated with blood that, if compressed, would release blood in a liquid or semi-liquid form, or items caked with dried blood capable of being released during handling. Other body fluids or tissues containing visible blood.
2. Human Body Fluids: Human body fluids in a liquid or semi-liquid state, including: semen, vaginal secretions, cerebral spinal fluid, synovial fluid, pleural fluid, pericardial fluid, peritoneal fluid, amniotic fluid, and saliva from dental procedures. Also includes any other human body fluids visibly contaminated with blood, and all body fluids in situations where it is difficult or impossible to differentiate between body fluids.
3. Microbiological Wastes: Laboratory wastes containing or contaminated with concentrated forms of infectious agents. Such waste includes discarded specimen cultures, stocks of etiologic agents, discarded live and attenuated viruses, blood or body fluids known to contain infectious pathogens, wastes from the production of biologicals and serums, disposable culture dishes, and devices used to transfer, inoculate and mix cultures (BSL-1 through BSL-4 etiologic agents as designated by NIH Guidelines/BSC).
4. Pathological waste: All human tissues, organs, and body parts, including waste biopsy materials, tissues, and anatomical parts from surgery, procedures, or autopsy. Any unfixed human tissue, except skin.
5. Animal waste: All animal carcasses, body parts, and any bedding material from animals known to be infected with, or that have been inoculated with human pathogenic microorganisms infectious to humans.
6. Sharps waste: As defined in Section 9, Sharps Waste. The wastes above must be treated, packaged, labeled, and transported as described in the following sections. Sharps waste procedures are described in Section 9, Sharps Waste.
7. Recombinant DNA and RNA: As defined in the NIH Guidelines. These wastes must be treated, packaged, labeled, and transported as described in the following sections or as determined appropriate on the EMUA and approved by the Institutional Biosafety Committee

https://extranet.fredhutch.org/en/u/ehs/hamm/chap6/section8.html

SERVPRO of North Arlington is here for all of your restoration needs